Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News ICON plc to acquire CRO PRA Health Sciences for $12bn ICON plc, an Ireland-based contract research organization (CRO), has agreed to acquire PRA Health Sciences in a cash-cum-stock… bySrinathFebruary 24, 2021
